Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-37.38Interest Coverage
VS
Market
Sector
Industry
History
$ 12.65Close
$ 10.25 - $ 49 52-Week Range
Ticker Information
Ticker
CBIOCompany Name
CRESCENT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCRESCENT BIOPHARMA INC - Interest Coverage Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CBIO - Int. Coverage Historical data
| Date | Earning Before Interest & Taxes (EBIT) | Interest Expense | Interest Coverage |
|---|---|---|---|
| 6/30/2025 | $ -40.11M | $ 1.07M | -37.38 |
| 3/31/2025 | $ -29.49M | $ 0 | 0 |
| 12/31/2024 | $ -37.88M | $ 0 | 0 |
| 9/30/2024 | $ -39.74M | $ 0 | 0 |
| 6/30/2024 | $ -39.11M | $ 0 | 0 |
| 3/31/2024 | $ -37.28M | $ 0 | 0 |
| 12/31/2023 | $ -36.9M | $ 0 | 0 |
| 9/30/2023 | $ -38.07M | $ 0 | 0 |
| 6/30/2023 | $ -37.39M | $ 0 | 0 |
| 3/31/2023 | $ -42.4M | $ 0 | 0 |
Key Performance Insights, Last 5 Years
- CRESCENT BIOPHARMA INC's latest trailing twelve months (TTM) Int. Coverage stands at 0.
- Over the past 5 years, CRESCENT BIOPHARMA INC's average Int. Coverage has been -37.38.
- The median Int. Coverage for CRESCENT BIOPHARMA INC during this period was -37.38
- CRESCENT BIOPHARMA INC reached its highest Int. Coverage over the past 5 years at -37.38.
- The lowest Int. Coverage recorded by CRESCENT BIOPHARMA INC in the same timeframe -37.38
Similar metrics to Int. Coverage:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Dividend Coverage - [Calculation] The Dividend Coverage Ratio, or dividend cover, describes how often a business can pay its annual dividend to its shareholders. The dividend coverage ratio is calculated by dividing the company’s Earnings per Share [EPS] by its Dividend per Share [DPS].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Interest Coverage
[Calculation] The Interest Coverage Ratio is a debt and profitability ratio that describes how easily a business can pay interest on its outstanding [Debt]. It is calculated by dividing the company’s earnings before interest and taxes [EBIT] by its interest expenses [IntExp].EBIT / Int. Exp.
(=) Int. Coverage Int. Coverage for CRESCENT BIOPHARMA INC is calculated as follows: EBIT [ $ -50.19M ] / Int. Exp. [ $ 0 ]
(=) Int. Coverage [ 0 ] CBIO - Interest Coverage, Last 5 years
-37.38
Minimum
Jun 30, 2025
-37.38
Maximum
Jun 30, 2025
-37.38
Average
-37.38
Median
Int. Coverage Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Coverage for companies in the Total Stock Market. The average Int. Coverage of the companies is 2.15 with a standard deviation of 8.46.
The following table provides additional summary stats:
Int. Coverage in the Market:
| filtered constituents | 2.37K |
|---|---|
| min | -25.49 |
| max | 28.75 |
| average | 2.15 |
| median | 2.08 |
| std | 8.46 |